A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats by Uthaug, M. V., Mason, N. L., Toennes, S. W., Reckweg, J. T., de Sousa Fernandes Perna, E. B., Kuypers, K. P. C., van Oorsouw, K., Riba, J., Ramaekers, J. G.

Get full text

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin by Mason, N L, Kuypers, K P C, Müller, F, Reckweg, J, Tse, D H Y, Toennes, S W, Hutten, N R P W, Jansen, J F A, Stiers, P, Feilding, A, Ramaekers, J G

Get full text

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study by Mason, N.L., Szabo, A., Kuypers, K.P.C., Mallaroni, P.A., de la Torre Fornell, R., Reckweg, J.T., Tse, D.H.Y., Hutten, N.R.P.W., Feilding, A., Ramaekers, J.G.

Get full text

Spontaneous and deliberate creative cognition during and after psilocybin exposure by Mason, N. L., Kuypers, K. P. C., Reckweg, J. T., Müller, F., Tse, D. H. Y., Da Rios, B., Toennes, S. W., Stiers, P., Feilding, A., Ramaekers, J. G.

Get full text

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N,N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers by Reckweg, J., Mason, N., Van Leeuwen, C., Tönnes, S., Terwey, T., Ramaekers, J.

Get full text

P.214 (Sub)acute effects of psilocybin on creative cognition: a double-blind, placebo-controlled experimental study by Mason, N., Kuypers, K., Reckweg, J., Muller, F., Ramaekers, J.

Get full text

P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective state by Mason, N., Kuypers, K., Reckweg, J., Tse, D., Muller, F., Toennes, S., Feilding, A., Ramaekers, J.

Get full text

A phase 1, dose-ranging trial to assess the safety and psychoactive effects of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation in healthy volunteers by Reckweg, J., Mason, N.L., van Leeuwen, C., Toennes, S.W., Terwey, T.H., Ramaekers, J.G.

Get full text

Neurochemical underpinnings of psychedelic-induced ego dissolution by Mason, N., Mallaroni, P., Kloft, L., Reckweg, J., Kuypers, K., Tse, D., van Oorsouw, K., Ramaekers, J.

Get full text

A phase 1/2 trial of a vaporized 5-Methoxy-N,N-Dimethyltryptamine formulation, in patients with treatment-resistant depression by Reckweg, J., van Leeuwen, C., Henquet, C., van Amelsvoort, T., Theunissen, E.L., Mason, N.L., Paci, R., Terwey, T.H., Ramaekers, J.G.

Get full text

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression by Reckweg, Johannes T, van Leeuwen, Cees J, Henquet, Cécile, van Amelsvoort, Therese, Theunissen, Eef L, Mason, Natasha L, Paci, Riccardo, Terwey, Theis H, Ramaekers, Johannes G

Get full text

Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience by Madrid-Gambin, Francisco, Gomez-Gomez, Alex, Busquets-Garcia, Arnau, Haro, Noemí, Marco, Santiago, Mason, Natasha L., Reckweg, Johannes T., Mallaroni, Pablo, Kloft, Lilian, van Oorsouw, Kim, Toennes, Stefan W., de la Torre, Rafael, Ramaekers, Johannes G., Pozo, Oscar J.

Get full text